·07/05/08 Acute graft-versus-host disease in patients with Fanconi anemia or acquired aplastic anemia undergoing bone marrow transplantation from HLA-identical sibling donors: risk factors and influence on outc
·07/05/08 Adult human hematopoietic cells provide functional hemangioblast activity
·07/05/08 Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
·07/05/08 Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors
·07/05/08 Bcl-xL antagonism of BCR-coupled mitochondrial phospholipase A2 signaling correlates with protection from apoptosis in WEHI-231 B cells
·07/05/08 CCL16 activates an angiogenic program in vascular endothelial cells
·07/05/08 Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency
·07/05/08 Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
·07/05/08 Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia
·07/05/08 Enhanced in vivo platelet adhesion in vasodilator-stimulated phosphoprotein (VASP)–deficient mice
·07/05/08 Ephrin receptor EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts blood cardiomyocytes and blood vessels
·07/05/08 Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies
·07/05/08 Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease
·07/05/08 Female agammaglobulinemia due to the Bruton tyrosine kinase deficiency caused by extremely skewed X-chromosome inactivation
·07/05/08 Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched related hematopoietic stem cell transplants
·07/05/08 FLT3 ligand causes autocrine signaling in acute myeloid leukemia cells
·07/05/08 FOP-FGFR1 tyrosine kinase, the product of a t(6;8) translocation induces a fatal myeloproliferative disease in mice
·07/05/08 Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers
·07/05/08 Hard time for anergic cytotoxic T cells
·07/05/08 Hemangioblasts in adults?
·07/05/08 Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients
·07/05/08 Hidden identity of Hodgkin/Reed-Sternberg cells
·07/05/08 Hopes for kinase inhibitors active against AML take FLT
·07/05/08 Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease
·07/05/08 Impact of frontline fludarabine and cyclophosphamide combined treatment on peripheral blood stem cell mobilization in B-cell chronic lymphocytic leukemia
·07/05/08 In vitro efficacy of combined treatment depends on the underlying mechanism of resistance in imatinib-resistant Bcr-Abl–positive cell lines
·07/05/08 Infection of HHV-8+ primary effusion lymphoma cells with a recombinant Epstein-Barr virus leads to restricted EBV latency, altered phenotype, and increased tumorigenicity without affecting TCL1 expres
·07/05/08 Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells
·07/05/08 Interleukin-6–dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family–independent survival pathway closely associated with Stat3 activation
·07/05/08 Jun N-terminal kinase activity and early growth-response factor-1 gene expression are down-regulated in Fanconi anemia group A lymphoblasts
·07/05/08 Ligation of CD137 receptor prevents and reverses established anergy of CD8+ cytolytic T lymphocytes in vivo
·07/05/08 Light at the end of the VOD tunnel?
·07/05/08 Little evidence of donor-derived epithelial cells in early digestive acute graft-versus-host disease
·07/05/08 Major questions after "minor" answers
·07/05/08 Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

1 [2] [下一页] [尾页]